Abraxane and anaemia Patient Reports February 11, 2012

Abraxane Side Effects Report #5946041-4
Abraxane side effect was reported by a Health Professional from UNITED STATES on Nov 06, 2008. Female patient, weighting 141.0 lb, was diagnosed with ovarian cancer recurrent and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, vaginal haemorrhage, vaginal neoplasm. Abraxane dosage: 260 MG/M2 ONCE EVERY 21 DAYS INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with VANDETANIB. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5927466-X
Abraxane side effect was reported by a Health Professional from UNITED STATES on Oct 21, 2008. Female patient, weighting 141.0 lb, was diagnosed with disease progression, disease recurrence and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anaemia, neoplasm progression, pain , vaginal haemorrhage, vaginal neoplasm. Abraxane dosage: 260 MG/M2 ONCE EVERY 21 DAYS IV. During the same period patient was treated with VANDETANIB. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5061113-7
Abraxane side effect was reported by a Health Professional from UNITED STATES on July 05, 2006. Female patient, 69 years of age, weighting 174.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, neutropenia, weight decreased. Abraxane dosage: (260 MG/M2, EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with ZOMETA, COMPAZINE, TOPROL, ASPIRIN. Patient recovered.

Abraxane Side Effects Report #5083644-6
Abraxane side effect was reported by a Health Professional from UNITED STATES on July 31, 2006. Female patient, 69 years of age, weighting 174.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, neutropenia, weight decreased. Abraxane dosage: unknown. During the same period patient was treated with ZOMETA, COMPAZINE, TOPROL, ASPIRIN. Patient recovered.


Abraxane Side Effects Report #5131458-0
Abraxane side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2006. Male patient, 66 years of age, weighting 223.8 lb, was diagnosed with breast cancer metastatic, anaemia of malignant disease, hypercholesterolaemia, neutropenia and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, chest pain , dehydration, dyspnoea, musculoskeletal chest pain, neutropenia, palpitations, pneumonia . Abraxane dosage: LAST DOSE PRIOR TO FIRST EVENT 28-APR-2006 (175 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with PROCRIT, CYTOXAN, DOXORUBICIN, ASPIRIN, NEUPOGEN, LIPITOR, LORTAB. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5030226-8
Abraxane side effect was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2006. Male patient, 66 years of age, was diagnosed with breast cancer metastatic, anaemia of malignant disease and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, pulmonary congestion, sinus tachycardia, supraventricular tachycardia. Abraxane dosage: (175 MG/M2, 1 IN 3 WEEKS) INTRAVENOUS DRIP. During the same period patient was treated with PROCRIT, CYTOXAN, ADRIAMYCIN PFS. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5030561-3
Abraxane side effect was reported by a Health Professional from UNITED STATES on May 31, 2006. Male patient, 66 years of age, weighting 254.0 lb, was diagnosed with breast cancer metastatic, anaemia of malignant disease and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, supraventricular tachycardia. Abraxane dosage: (175 MG/M2, 1 IN 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with PROCRIT, CYTOXAN, DOXORUBICIN. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5104936-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2006. Female patient, 47 years of age, weighting 112.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: abscess limb, anaemia, blood calcium decreased, blood chloride increased, blood glucose increased, blood potassium increased, blood urea increased, dehydration, electrolyte imbalance. Abraxane dosage: 155MG X 1 DOSE (SCHEDULED EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with CARBOPLATIN, AVASTIN, NEXIUM, ADVIL, OXYCODONE. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5371560-1
Abraxane side effect was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2007. Female patient, 63 years of age, was diagnosed with breast cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: anaemia, aphthous stomatitis, headache , nausea , pneumonia , sinusitis , toothache. Abraxane dosage: 175MG WEEKLY IV. During the same period patient was treated with ACYCLOVIR, COUMADIN, TYLENOL, IBUPROFEN, OMEPRAZOLE, VITAMIN B6. Patient was hospitalized. Patient recovered.